Trending...
- Harborside Senior Living CEO Making Assisted Living More Affordable in Monroe County Ask About Up to $25K in Annual Care Support - 134
- Most Utah Deaths Never Reach the Medical Examiner. Postmortem Pathology Offers Salt Lake City a Private Autopsy Option - 123
- Virtually Tour Heritage at South Brunswick's Resort-Style Living - Experience Indoor and Outdoor Amenities at Your Fingertips - 119
VALFIX Medical is developing a trans-catheter solution for patients suffering from valvular heart disease and heart failure.
DOVER, Del. - Michimich -- VALFIX Medical Inc. announces the issuance of a new patent by its Israeli subsidiary VALFIX Medical Ltd. The new Patent US 11,931,021 B2 is titled "Anchors and locks for percutaneous valve implants".
The granted patent outlines multiple locking mechanisms that secure an implant to its target location by applying gripping forces on a surgical suture that passes through the implant.
"It is exciting to receive the new patents as we continue to push the technology forward; our approach to valve repair remains unique and distinct in the market," stated Eli Bar, CEO and Founder of VALFIX Medical. "This patent granted confirms and protects our core technology and adds significant value to our stakeholders."
More on Michimich.com
VALFIX Medical technology is distinguished in its approach to offer valve repair method that truly replicate the surgical annuloplasty approach. Using specially designed anchors and locks VALFIX achieve unparalleled operational flexibility, anatomic precision, and implant stability.
This unique approach gives more options for interventional cardiologists to deliver the most effective therapy to this complex condition.
About VALFIX Medical:
VALFIX has developed an innovative transcatheter system to treat heart failure patients suffering from significant functional mitral valve regurgitation (FMR). VALFIX's unique and innovative transcatheter technology offers a viable alternative to open heart surgery.
To learn more about VALFIX Medical visit our website at www.valfixmed.com or
contact us directly at info@valfixmed.com
The granted patent outlines multiple locking mechanisms that secure an implant to its target location by applying gripping forces on a surgical suture that passes through the implant.
"It is exciting to receive the new patents as we continue to push the technology forward; our approach to valve repair remains unique and distinct in the market," stated Eli Bar, CEO and Founder of VALFIX Medical. "This patent granted confirms and protects our core technology and adds significant value to our stakeholders."
More on Michimich.com
- Harborside Senior Living CEO Making Assisted Living More Affordable in Monroe County Ask About Up to $25K in Annual Care Support
- CardsNearby Launches Free Nationwide Directory of Card Shows and Local Card Shops for Collectors
- Anton Williams Holding Company Announces Reformed Neo Calvinist Corporate Purpose Statement
- American Garden Rose Selections™ Announces 2027 Winners
- Crossroads4Hope Launches Blood Cancer Resource Hub
VALFIX Medical technology is distinguished in its approach to offer valve repair method that truly replicate the surgical annuloplasty approach. Using specially designed anchors and locks VALFIX achieve unparalleled operational flexibility, anatomic precision, and implant stability.
This unique approach gives more options for interventional cardiologists to deliver the most effective therapy to this complex condition.
About VALFIX Medical:
VALFIX has developed an innovative transcatheter system to treat heart failure patients suffering from significant functional mitral valve regurgitation (FMR). VALFIX's unique and innovative transcatheter technology offers a viable alternative to open heart surgery.
To learn more about VALFIX Medical visit our website at www.valfixmed.com or
contact us directly at info@valfixmed.com
Source: Valfix medical Inc.
0 Comments
Latest on Michimich.com
- OneVizion Appoints Energy Infrastructure Executive Walt Farrell to Board of Directors
- Tampa Bay Reporter Launches with a Mission to Deliver Local News with National Reach
- "JACKIE the STRIPPER," Starring Charlotte Kirk and The PUSSYCAT DOLLS' Kimberly Wyatt, Now Streaming on PRIME
- Migguel Anggelo Celebrates the Immigrant Experience, Latino Identity, and the Power of Iconic Latin Rhythms During Hispanic Heritage Month
- Indianapolis Criminal Defense Firm Rigney Law LLC Relaunches Criminal Law Podcast "Tales from the Brown Desk"
- 3ptechies Makes Its Articles Audio-Ready With Instaread Voice Technology
- Genuine Hospitality, LLC Selected to Operate Fairfield Inn & Suites Tampa Wesley Chapel
- Pregis to Highlight EPR Expertise, Sustainable Packaging Solutions and Live Automation Demonstrations at Pack Expo International 2026
- Infinity Infusion Solutions Launches "Women Leading Infusion Care" Campaign for National Women in Business Month
- HuskyTail Digital Puts AI to Work Behind the Scenes to Cut Client Turnaround Time
- AI, Real-World Data "RWD" and U.S. Expansion Put Predictive Healthcare in Focus for POMDOCTOR Ltd. (N A S D A Q: POM)
- $11.18 Million DARPA Award Ignites a Major New Catalyst as FDA, Robotic TMS and Commercialization Milestones Converge for NRx Pharmaceuticals, Inc
- Hidden Storm Damage Could Turn Into Winter Leaks for Homeowners
- P-Wave Classics to publish Thomas Holcroft's The Adventures of Hugh Trevor in three volumes, beginning 19 January
- Ad Leverage Sponsors ServiceTitan Pantheon 2026, Supporting Education and Growth in the Home Services Industry
- DBF Viewer 2000 v9.32 Adds New Control for Data Export
- Badanamu Partners With Moonbug Entertainment In Landmark Distribution Deal
- Nutriband (N A S D A Q: NTRB): Fighting Back Against the Fentanyl Crisis With a New Approach to Safer Transdermal Medicines
- Oral statement on the situation of Chairman Lee Man-hee in pretrial detention in the Republic of Korea
- ESPEC North America Welcomes Zeke Fuentes as Regional Sales Manager - East Coast